Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccines

Infection and Immunity

Volumn 70, Issue 10, 2002, Pages 5479-5484

  Janakova, Libuse ^a   Bakke, Hilde ^a   Haugen, Inger Lise ^a   Berstad, Aud K H ^a   Høiby, E Arne ^a   Aaberge, Ingeborg S ^a   Haneberg, Bjørn ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; IMMUNOGLOBULIN G; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG FORMULATION; FECES; FEMALE; GENERAL ANESTHESIA; IMMUNE SYSTEM; IMMUNIZATION; LOWER RESPIRATORY TRACT; LUNG PARENCHYMA; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SALIVA; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANESTHESIA, INTRAVENOUS; ANIMALS; ANTIBODIES, VIRAL; ANTIGEN PRESENTATION; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INFLUENZA VACCINES; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C;

EID: 0036784664     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.10.5479-5484.2002     Document Type: Article

References (29)

1. Virulence of Streptococcus pneumoniae in mice: A standardized method for preparation and frozen storage of the experimental bacterial inoculum
2. Oral and nasal immunization with microencapsulated clinically relevant proteins
3. Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine
4. A nasal whole-cell pertusis vaccine induces specific systemic and crossreactive mucosal antibody responses in human volunteers
5. A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin
6. Is total particle dose more important than particle distribution?
7. Intravascular and mucosal immunoglobulin A: Two separate but related systems of immune defense?
8. Outer membrane vesicles can act as mucosal adjuvant for influenza virus antigens
9. Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasal to mice
10. Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen
11. Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers
12. Production, characterization and control of MenB-vaccine "Folkehelsa": An outer membrane vesicle against group B meningococcal disease
13. Intranasal immunization with proteoliposomes protects against influenza
14. Intranasal administration of a meningococcal outer membrane vesicle induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans
15. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina, measured by a new method for collection of secretions from local mucosal surfaces
16. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: A brief survey
17. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection
18. The role of nasopharyngeal lymphoid tissue
19. Epithelial M cells: Gateways for mucosal infection and immunization
20. Is BALT a major component of the human lung immune system?
21. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccine among young adults in Iceland
22. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine
23. Immunogenicity of intranasal administered meningococcal native outer membrane vesicles in mice
24. Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract
25. Structure and function of bronchus associated lymphoid-tissue (BALT)
26. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation
27. Optimal induction of upper respiratory tract immunity to reovirus 1/L by combined upper and lower respiratory tract inoculation
28. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue
29. Outcome of influenza infection: Effect of site of initial infection and heterotypic immunity